Artikel ; Online: The Kaposi's Sarcoma-Associated Herpesvirus (KSHV) gH/gL Complex Is the Predominant Neutralizing Antigenic Determinant in KSHV-Infected Individuals.
2020 Band 12, Heft 3
Abstract: ... to which various KSHV envelope glycoproteins (gB, ORF28, ORF68, gH, gL, gM, gN and gpK8.1) adsorbed/removed KSHV ... individuals. Importantly, among the KSHV glycoproteins, the gH/gL complex, but neither gH nor gL alone, showed ... individuals regardless of their KS status. The findings suggest that the gH/gL complex is the predominant ...
Abstract | Kaposi's sarcoma-associated herpesvirus (KSHV) is the etiological agent of Kaposi's sarcoma (KS), one of the most prevalent cancers of people living with HIV/AIDS in sub-Saharan Africa. The seroprevalence for KSHV is high in the region, and no prophylactic vaccine against the virus is available. In this study, we characterized the antigenic targets of KSHV-specific neutralizing antibodies (nAbs) in asymptomatic KSHV-infected individuals and KS patients with high nAbs titers. We quantified the extent to which various KSHV envelope glycoproteins (gB, ORF28, ORF68, gH, gL, gM, gN and gpK8.1) adsorbed/removed KSHV-specific nAbs from the plasma of infected individuals. Our study revealed that plasma from a majority of KSHV neutralizers recognizes multiple viral glycoproteins. Moreover, the breadth of nAbs responses against these viral glycoproteins varies among endemic KS, epidemic KS and asymptomatic KSHV-infected individuals. Importantly, among the KSHV glycoproteins, the gH/gL complex, but neither gH nor gL alone, showed the highest adsorption of KSHV-specific nAbs. This activity was detected in 80% of the KSHV-infected individuals regardless of their KS status. The findings suggest that the gH/gL complex is the predominant antigenic determinant of KSHV-specific nAbs. Therefore, gH/gL is a potential target for development of KSHV prophylactic vaccines. |
---|---|
Mesh-Begriff(e) | Adult ; Aged ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/immunology ; Epitopes/immunology ; Female ; Genetic Vectors/genetics ; HEK293 Cells ; Herpesviridae Infections/immunology ; Herpesviridae Infections/virology ; Herpesvirus 8, Human/physiology ; Humans ; Male ; Middle Aged ; Sarcoma, Kaposi ; Viral Envelope Proteins/immunology ; Viral Load ; Young Adult |
Chemische Substanzen | Antibodies, Neutralizing ; Antibodies, Viral ; Epitopes ; Viral Envelope Proteins |
Sprache | Englisch |
Erscheinungsdatum | 2020-02-26 |
Erscheinungsland | Switzerland |
Dokumenttyp | Journal Article ; Research Support, N.I.H., Extramural |
ZDB-ID | 2516098-9 |
ISSN | 1999-4915 ; 1999-4915 |
ISSN (online) | 1999-4915 |
ISSN | 1999-4915 |
DOI | 10.3390/v12030256 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.